Back

Left bundle branch pacing and mechanical desynchrony: a real-world perspective

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in device therapy (1) Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emidio Mata

Unidade Local de Saude do Alto Ave - Hospital Senhora da Oliveira - Guimaraes, Creixomil (Portugal)

6 More presentations in this session

Presentation thumbnail
Safety and complications of subcutaneous ICDs in a remote center: a real-world analysis
Doctor I. Santos (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
TRV/TAPSE ratio as a predictor of response to left bundle branch area pacing in heart failure patients
Associate Professor S. Murat (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Temporal trends of cardiac remodelling following cardiac resynchronization therapy with biventricular or conduction system pacing
Mr T. Zlahtic (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Acute impact of cardiac resynchronization on retinal vascular function
Doctor V. Rossi (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Left bundle branch area pacing to achieve physiological conduction system activation - the experience of a center
Doctor M. Bernardo (Vila Real, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in device therapy (1)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Impact of left bundle branch area pacing on right cardiac chambers dimensions and function. a medium term single center echocardiographic study
thumbnail
Congress Presentation
The learning curve of left bundle branch area pacing: feasibility, safety, acute success rates and echocardiographic assessment of mechanical dyssynchrony
thumbnail
Congress Presentation
Comparison of left bundle branch area pacing and biventricular pacing in patients with class I indication for resynchronization therapy: preliminary results of the prospective randomized study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources